Umesh Mishra - Aug 30, 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role: Chief Technology Officer, Director
Signature: /s/ Cameron McAulay, Attorney-in-Fact
Stock symbol: TGAN
Transactions as of: Aug 30, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/1/2023, 04:04 PM
Previous filing: Jul 25, 2023
Next filing: Nov 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TGAN	Common Stock	Award	$0	+173K	+90.04%	$0.00	365K	Aug 30, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TGAN	Stock Option (right to buy)	Award	$0	+115K		$0.00	115K	Aug 30, 2023	Common Stock	115K	$2.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a Restricted Stock Unit ("RSU"). One twelfth (1/12) of the RSUs will vest on September 1, 2024, and the remaining RSUs vest in equal quarterly installments over the following 11 quarters, subject to the Reporting Person's continued service as of each such vesting date.
F2	One-fourth (1/4) of the shares subject to the option will vest on September 1, 2024, and the remaining shares vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service as of each such vesting date.